Iowa Code §§ 510B.1 through 510B.10: Regulation of Pharmacy Benefits Managers – Iowa
Status: Enacted Year Enacted: 2007
The commissioner may require a pharmacy benefits manager to submit information to the commissioner related to the pharmacy benefits manager’s pricing methodology for maximum reimbursement amount.
Download
Kan. Stat. Ann. §§ 39-7,116 through 7,121g: Drug Utilization Review Program – Kansas
Status: Enacted Year Enacted: 1990
The secretary of health and environment shall implement a drug utilization review program with the assistance of a medicaid drug utilization review board as provided in K.S.A. 39-7,119, and amendments thereto, to assure the appropriate …
Download
Kan. Stat. Ann. §§ 65-1625 through 1626a: Pharmacy Act of the State of Kansas – Kansas
Status: Enacted Year Enacted: 1953
Deletes, adds, and modifies definitions to be consistent with federal standards; modifies the requirements for processing prescription orders to prohibit pharmacists from exercising brand exchange for a biological product; inserts provisions to bring the Act …
Download
Kan. Stat. Ann. §§ 65-1637 through 1637e: Regulation of Pharmacists – Kansas
Status: Enacted Year Enacted: 1953
A pharmacist who receives a prescription order for a brand name drug product, excluding a biological product, may exercise brand exchange with a view toward achieving a lesser cost to the purchaser unless the following …
Download
Ky. Rev. Stat. § 304.17A-535. Drug utilization waiver program; limitations on generic substitution; application to drug formulary: Managed Care Plans – Kentucky
Status: Enacted Year Enacted: 1998
A managed care plan shall include a drug utilization review program. A managed care plan that restricts pharmacy benefits to a drug formulary shall have an exceptions policy through which the managed care plan may …
Download
LB 481 – Nebraska
Introduced: 2017 Status: Enacted
PROVIDE FOR DRUG PRODUCT SELECTION FOR INTERCHANGEABLE BIOLOGICAL PRODUCTS: LB481 updates Nebraska Statutes to allow for the substitution of biologic products only with FDA approved interchangeable biologics. Current state law governs the substitution by pharmacists …
LD 1280 (see companion bill SP 432) – Maine
Introduced: 2017 Status: Enacted Year Enacted: 2018
AN ACT REGARDING GENERIC DRUG PRICING. This bill amends the Maine Pharmacy Act to require that a drug distributed in this State must be made available for sale in this State to a person seeking …
LD 1389 – Maine
Introduced: 2019 Status: Inactive / Dead
This bill requires that pharmacy benefit managers, which are entities that manage an insurer’s prescription drug coverage, be registered by the Department of Health and Human Services. It sets standards for registration including the following.
LD 1706 – Maine
Introduced: 2021 Status: Inactive / Dead
An Act To Require Appropriate Coverage of and Cost-sharing for Generic Drugs and Biosimilars
Md. Code, Health-Gen. § 15-118. Prescription drugs; use, reimbursement: Medical and Pharmacy Assistance Programs – Maryland
Status: Enacted Year Enacted: 1982
Unless the prescriber directs otherwise on the form or on an attached signed certification of need, the generic form of the drug authorized under § 12-504 of the Health Occupations Article shall be used to …
Download
Md. Code, Health-Gen. §§ 15-101 through 15-149: Medical and Pharmacy Assistance Programs – Maryland
Status: Enacted Year Enacted: 1982
This section established the MD Medicaid expansion, which the Secretary shall administer. Enrollment standards and processes shall comply with this section. The Program shall use its leverage as a high volume purchaser to promote the …
Download
Md. Code, Health-Gen. §§ 2-801 through 2-803: Prohibition Against Price Gouging for Essential Off-Patent or Generic Drugs – Maryland
Status: Enacted Year Enacted: 2017
A manufacturer or wholesale distributor may not engage in price gouging in the sale of an essential off-patent or generic drug. It is not a violation of subsection (a) of this section for a wholesale …
Download
Mich. Comp. Laws § 17704 – Michigan
Status: Enacted
Permit a pharmacist who receives a prescription for a brand name drug product or biological drug product to dispense a lower cost generically equivalent drug product or interchangeable biological drug product if available in the …
Mich. Comp. Laws § 333.17702 – Michigan
Status: Enacted
Permit a pharmacist who receives a prescription for a brand name drug product or biological drug product to dispense a lower cost generically equivalent drug product or interchangeable biological drug product if available in the …
Mich. Comp. Laws § 333.17755 – Michigan
Status: Enacted
Permit a pharmacist who receives a prescription for a brand name drug product or biological drug product to dispense a lower cost generically equivalent drug product or interchangeable biological drug product if available in the …
Mo. Rev. Stat. § 338.056 – Missouri
Status: Enacted
Modifies current law regarding written prescriptions to permit a pharmacist who receives a prescription for a brand name drug or biological product to select a less expensive generically equivalent drug or interchangeable biological product unless …